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Abstract
There is a dearth of robust methods to estimate the causal effects of multiple treatments when the outcome is binary.
This paper uses two unique sets of simulations to propose and evaluate the use of Bayesian Additive Regression
Trees (BART) in such settings. First, we compare BART to several approaches that have been proposed for continuous
outcomes, including inverse probability of treatment weighting (IPTW), targeted maximum likelihood estimator (TMLE),
vector matching and regression adjustment. Results suggest that under conditions of non-linearity and non-additivity
of both the treatment assignment and outcome generating mechanisms, BART, TMLE and IPTW using generalized
boosted models (GBM) provide better bias reduction and smaller root mean squared error. BART and TMLE provide
more consistent 95 per cent CI coverage and better large-sample convergence property. Second, we supply BART with
a strategy to identify a common support region for retaining inferential units and for avoiding extrapolating over areas
of the covariate space where common support does not exist. BART retains more inferential units than the generalized
propensity score based strategy, and shows lower bias, compared to TMLE or GBM, in a variety of scenarios differing
by the degree of covariate overlap. A case study examining the effects of three surgical approaches for non-small cell
lung cancer demonstrates the methods.
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Introduction
Motivating Research Question
Lung cancer is the leading cause of cancer-related mortality worldwide and is estimated to have caused over 1.7 million
deaths in 20181. The most common type of lung cancer is non-small cell lung cancer (NSCLC), accounting for approximately
85% of all lung cancer cases2. When feasible, NSCLC tumors are treated using surgical resection, which remains the most
effective option for a cure3.
Open thoracotomy long stood as the standard surgical procedure for stage I-IIIA NSCLC tumors. However, open
thoracotomy is associated with considerable postoperative complications and mortality, especially in the elderly4,5.
Beginning in the late 1990s, two newer and less invasive techniques, video-assisted thoratic surgery (VATS) and, more
recently, robotic-assisted surgery, were increasingly used6,7. The adoption of VATS and robotic-assisted surgery seemed
to signal that the newer procedures offer a clinical benefit relative to open resection8,9. However, to our knowledge, no
randomized controlled trials (RCTs) have been conducted to compare the effectiveness of these surgical procedures, in part
due to difficulties in recruiting patients and high study costs. As a consequence, VATS and robotic-approaches were adopted
into routine care without sufficient scrutiny6,10.
In place of RCTs, large-scale population-based databases, such as the Surveillance, Epidemiology, and End Results
(SEER)-Medicare database, provide research opportunities for comparative studies. The SEER-Medicare database comprises
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a large sample of patients who received each of the three surgical procedures and reflects patient outcomes in the real world
setting, containing demographic and clinical information for Medicare beneficiaries with cancer in various United States
regions11. However, in contrast to RCTs, the real-world adoption pattern of the three surgical approaches largely depends
on the patients’ sociodemographic and tumor characteristics, which may result in an unbalanced cohort with significant
differences in the distributions of sociodemographic characteristics, comorbidities, cancer characteristics and diagnostic
information across treatment groups12.
The research question poses several challenges for statistical analyses. First, in practice, statistical methods designed
for a binary treatment are often used to account for underlying differences in patient characteristics to compare each pair
of surgical procedures6,10,13. Unfortunately, applications of these methods can lead to the comparisons of disparate patient
subgroups, which may increase bias in treatment effect estimates14. Second, common measures for comparative effectiveness
are postoperative complications, which are binary outcomes. Thus, the treatment effects are typically based on the risk
difference (RD), odds ratio (OD) or relative risk (RR)15, all of which make it less straightforward to obtain inference,
relative to continuous outcomes16–18. Third, the robotic-assisted surgery is a new advanced technology that was just adopted
into practice in recent years. As a result, the number of patients who are operated via this approach is smaller compared to
the other two approaches, yielding unequal sample sizes across the treatment groups. Appropriate causal inference methods
that can address these challenges are needed.
Overview of Methods for Causal Inference with Multiple Treatments
Recent years have seen a growing interest in the development of causal inference methods with multiple treatments using
observational data. The theoretical work of Imbens19 and Imai and Van20 extended the propensity score framework in the
setting with a binary treatment21 to the general treatment setting. Subsequently, methods designed for a binary treatment
have been reformulated to accommodate multiple treatments, including regression adjustment (RA)22, inverse probability
of treatment weighting (IPTW)23,24, and vector matching (VM)14. Lopez and Gutman14 provide a comprehensive review of
current methods for multiple treatments. These methods focus on continous outcomes.
RA22,25,26, also known as model-based imputation27 uses a regression model to impute missing outcomes, estimating what
would have happened to a specific unit had this unit received the treatment to which it was not exposed. The causal estimand
of interest can be estimated by contrasting the imputed potential outcomes between treatment groups. The critical part of
this method is the specification of the functional form of the regression model. With a low-dimensional set of pre-treatment
covariates, it is relatively easy to specify a flexible functional form for the regression model. If there are many pre-treatment
covariates, however, such a specification is more difficult, and possible misspecification of the regression model could bias
the estimate of treatment effects. RA also heavily relies on extrapolation for estimation when the covariate distributions
between treatment groups are far apart27.
IPTW19,23,24 methods attempt to obtain an unbiased estimator for treatment effects in a way akin to how weighting by
the inverse of the selection probability adjusts for unbalances in sampling pools, introduced by Horvitz and Thompson28
in survey research. A challenge with IPTW is that treated units with low generalized propensity scores that are close to
zero can result in extreme weights, which may yield erratic causal estimates with large sample variances29,30. This issue is
increasingly likely as the number of treatments increases14. An alternative method is to use trimmed or truncated weights, in
which weights that exceed a specified threshold are each set to that threshold31,32. The threshold is often based on quantiles
of the distribution of the weights (e.g., the 1st and 99th percentiles).
Alternatives to estimate generalized propensity scores in the IPTW framework include generalized boosted models24
(GBM) and Super Learner33,34 (SL). GBM grows multiple regression trees to capture complex and nonlinear relationships
between treatment assignment and pre-treatment variables. The estimation procedure can be tuned to find the generalized
propensity score model producing the best covariate balance between treatment groups. This feature of GBM should help
alleviate extreme weights and improve the estimation of causal effects24. However, the algorithm can be computationally
intensive, and the robust procedure for estimating the variances of the effect estimates is not guaranteed to result in
proper confidence intervals. SL uses ensemble of machine learning approaches including regression, ridge regression, and
classification trees, to estimate a weight for each treatment. There is no guarantee that these probabilities sum to 1, and it is
common to normalize weights accordingly. To limit extreme weights, Rose and Normand34 use a lower bound of 0.025 for
each probability.
Targeted Maximum Likelihood Estimation34,35 (TMLE) is a doubly robust approach that combines outcome estimation,
IPTW estimation, and a targeting step to optimize the parameter of interest with respect to bias/variance. Rose and
Normand34 implements TMLE by estimating both generalized propensity scores and a binary outcome using SL. For
obtaining variance estimates, Rose and Normand34 uses influence curves, though bootstrapping is also suggested. The use
of TMLE has, to the best of our knowledge, not been deeply vetted for multiple treatment options by using simulations.
Lopez and Gutman14 proposed the VM algorithm, which can match units with similar vector of generalized propensity
scores. VM is designed to replicate a multi-arm randomized trial by generating sets of units that are roughly equivalent
on measured pre-treatment covariates. VM obtains matched sets using a combination of k-means clustering and one-
to-one matching with replacement within each cluster strata. Simulations demonstrated that, relative to IPTW with the
generalized propensity scores estimated using multinomial logistic regression, and to generalizations of tools designed for
binary treatment, VM yielded lower bias in the covariates’ distributions between different treatment groups, while retaining
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most of eligible units that received the reference treatment14. However, the authors acknowledge that there is a lack of
guidance regarding the estimation of the sampling variance, and this is an area for further statistical research.
Before describing BART – one tool that we think is equipped to handle the complexity of causal inference with multiple
treatments – it is worth explicating on why one approach that, although intuitive and easy to perform, is not recommended: a
series of binary comparisons (SBC). To wit, grouping subjects into separate sub-populations, each with two treatments, and
then using approaches designed for binary treatment is an approach often used in practice14. However, SBC can (i) lead to
non-transitive causal estimates, (ii) increase bias, and (iii) leave it unclear which treatment is optimal, all of which make it
inappropriate for causal inference when there are more than two treatments14.
Bayesian Additive Regression Trees for Causal Inference
While the advanced regression and propensity score-based techniques described above were created for causal inference with
multiple treatments, these methods were developed with continuous outcomes in mind, and they have been less studied in
the context of both a binary outcome and multiple treatments.
In recent years, Bayesian Additive Regression Trees (BART)36,37, a nonparametric modeling tool, has become more
popular in causal settings. Hill38 proposed the use of BART for causal inference with a binary treatment and a continuous
outcome. Hill38 and Hill and Su39 used simulations to show that, in scenarios where there are nonlinearities in the response
surface and the treatment assignment mechanism, BART generates more accurate estimates of average treatment effects
compared to various matching and weighting techniques, and comparable estimates in linear settings.
BART boasts several advantages for causal inference with a binary treatment38,40. First, BART allows for an extremely
flexible functional form. Second, BART avoids ambiguity with respect to covariate balance diagnostics required by
propensity score based approaches. Third, BART generates coherent uncertainty intervals for treatment effect estimates from
the posterior samples in contrast to propensity score matching and subclassification, for which there is lack of agreement
regarding appropriate interval estimation20,38. Finally, BART is easy to implement and requires less researcher programming
expertise. However, like any methods that do not first discard units that fall out of areas of the covariate space where common
support does not exist, one vulnerability of BART is that there is no mechanism to prevent it from extrapolating over these
areas.
We surmise that the strengths of BART are transferable to the multiple treatment setting. In the sections that follow,
we conduct two sets of simulations to investigate the operating characteristics of BART for estimating the causal effects
of multiple treatments on a binary outcome, and compare BART to the existing methods discussed previously. We further
supply BART with a strategy to identify a common support region and compare it to the propensity score based strategy with
respect to the proportion of units retained for inference and the accuracy of treatment effect estimates based on the retained
inferential units. We subsequently apply the methods examined to analyze a large data set on stage I-IIIA NSCLC patients,
drawn from the SEER-Medicare registry, and estimate the comparative effect of robotic-assisted surgery versus VATS and
open thoracotomy on postoperative outcomes.
Potential Outcomes Framework for Multiple Treatments
Notation and Assumptions
Our notation is based on the potential outcomes framework, which was originally proposed by Neyman41 in the context of
randomization-based inference in experiments. Potential outcomes were generalized to observational studies and Bayesian
analysis by Rubin42–44, in what is now known as the Rubin Causal Model (RCM)45.
Consider a sample of N units, indexed by i = 1, . . . , N , drawn randomly from a target population, which comprises
individuals in a study designed to evaluate the effect of a treatment W on some outcome Y . Each unit is exposed to one of
total Z possible treatments; that is, Wi = w if individual i was observed under treatment w, where w ∈ W = {1, 2, . . . , Z}.
The number of units receiving treatment w is nw, where
∑Z
w=1 nw = N . For each unit i, there is a vector of pre-treatment
covariates, Xi, that are not affected by Wi. Let Yi be the observed outcome of the ith unit given the assigned treatment,
and {Yi(1), . . . , Yi(Z)} the potential outcomes for the ith unit under each treatment of W . For each unit, at most one
of the potential outcomes is observed (the one corresponding to the treatment to which the unit is exposed). All other
potential outcomes are missing, which is known as the fundamental problem of causal inference45. Let r(w,Xi) be
the generalized propensity score (GPS), which is defined as the probability of receiving treatment w given pre-treatment
covariates, that is, r(w,Xi) = Pr(Wi = w|Xi), for ∀ w ∈ {1, . . . , Z}19,20. This definition extends the propensity score21
from a binary treatment setting to the multiple treatment setting, in which conditioning must be done on a vector of GPSs,
defined as R(Xi) = (r(1,Xi), . . . , r(Z,Xi)), or a function of R(Xi)20. In addition, we define the response surface as
f(w,Xi) ≡ E[Yi(w)|Xi], for w ∈ {1, . . . , Z}.
In general, causal effects are not identifiable without further assumptions because only one of the potential outcomes is
observed for every unit. We make the following identifying assumptions:
1. The stable unit treatment value assumption (SUTVA)46, that is, no interference between units and no different versions
of a treatment.
Prepared using sagej.cls
4 Journal Title XX(X)
2. The positivity or sufficient overlap assumption; that is, 0 < p(Wi|Yi(1), . . . , Yi(Z),Xi) < 1, ∀Wi ∈ {1, . . . , Z},
which implies that there are no values of pre-treatment covariates that could occur only among units receiving one of
the treatments.
3. The treatment assignment is unconfounded; that is, p(Wi|Yi(1), . . . , Yi(Z),Xi) = p(Wi|Xi), ∀Wi ∈ {1, . . . , Z},
which implies that the set of observed pre-treatment covariates,Xi, is sufficiently rich such that it includes all variables
directly influencing both Wi and Yi; in other words, there is no unmeasured confounding.
Under the unconfoundedness assumption, for any treatment w and pre-treatment covariatesXi,
f(w,Xi) = E[Yi(w)|Wi = w,Xi] = E[Yi|Wi = w,Xi], (1)
where the second identity is the conditional mean function of the observed outcomes.
Definition of Causal Effects
Causal effects are summarized by estimands, which are functions of the unit-level potential outcomes on a common set of
units42,44. For dichotomous outcomes, causal estimands can be the RD, OD or RR. For purposes of illustration, we use RD
in this paper.
Following Lopez and Gutman14, we provide a broad definition of the causal risk difference that may be of interest with
multiple treatments. Define s1 and s2 as two subgroups of treatments such that s1, s2 ⊂ W and s1 ∩ s2 = ∅. Next, let |s1|
and |s2| be the cardinality of s1 and s2, respectively. Two commonly used causal estimands are the average treatment effect
(ATE), ATEs1,s2 , and the average treatment effect among those receiving s1, ATTs1|s1,s2 , where
ATEs1,s2 = E
[∑
w∈s1 Yi(w)
|s1| −
∑
w′∈s2 Yi(w
′)
|s2|
]
,
ATTs1|s1,s2 = E
[∑
w∈s1 Yi(w)
|s1| −
∑
w′∈s2 Yi(w
′)
|s2|
∣∣∣∣Wi ∈ s1]. (2)
In (2), the expectation is over all units, i = 1, . . . , N , and the summation is over the potential outcomes of a specific unit.
Another set of causal estimands are the conditional treatment effects, given pre-treatment covariatesXi,
CATEs1,s2 = E
[∑
w∈s1 Yi(w)
|s1| −
∑
w′∈s2 Yi(w
′)
|s2|
∣∣∣∣Xi; θY |X]
CATTs1|s1,s2 = E
[∑
w∈s1 Yi(w)
|s1| −
∑
w′∈s2 Yi(w
′)
|s2|
∣∣∣∣Wi ∈ s1,Xi; θY |X] (3)
where the parameters θY |X and θX index the conditional distribution p(Y |X) and distribution p(X), respectively.
Causal inference methods via modeling the response surfaces (e.g., BART and RA) arrive at the population or sample
marginal treatment effects by integrating the conditional effects over the distribution of Xi 47. In most cases, however, it is
difficult to model the possibly multi-dimensionalXi. We can obtain the marginal effects by averaging the treatment effects
conditional on the observed values of the covariates over the empirical distribution of {Xi}Ni=1,
ATEs1,s2 =
∫
CATEs1,s2(X, θY |X)dFX(X; θX)
ATTs1|s1,s2 =
∫
CATTs1|s1,s2(X, θY |X)dFX(X; θX),
(4)
In our motivating example, one of the research questions of interest is to compare the effectiveness of a newer minimally-
invasive procedure (i.e., robotic-assisted surgery) versus the existing surgical procedures (e.g., VATS) in the overall
population, or among those patients who received robotic-assisted surgery. The corresponding target causal estimands are
defined as
ATE1,2 =
∫
E[Yi(1)− Yi(2)|Xi; θY |X ]dFX(X; θX)
ATT1|1,2 =
∫
E[Yi(1)− Yi(2)|Wi = 1,Xi; θY |X ]dFX(X; θX).
(5)
Treatment effects using BART
Under the identifying assumptions, treatment effects such as ATT1|1,2 can be estimated by contrasting the imputed potential
outcomes between robotic-assisted surgery and VATS groups among those patients who received robotic-assisted surgery,
predicted from the estimates of the respective response surface models. In principle, any method that can flexibly estimate
f(w,Xi) could be used to predict the potential outcomes.36,37 demonstrated that BART has important advantages as a
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predictive algorithm over alternative methods in the machine learning literature such as classification and regression trees48,
boosting49 and random forests50, in particular with regard to choosing tuning parameters and generating coherent uncertainty
intervals.
BART is a Bayesian ensemble method that models the mean outcome given predictors by a sum of trees. For a binary
outcome, the BART model can be expressed using the probit model setup as:
f(w,Xi) = E(Yi|Wi = w,Xi) = Φ
{ J∑
j=1
gj(w,Xi;Tj ,Mj)
}
, (6)
where Φ is the the standard normal c.d.f., each (Tj ,Mj) denotes a single subtree model in which Tj denotes the regression
tree and Mj is a set of parameter values associated with the terminal nodes of the jth regression tree, gj(w,Xi) represents
the mean assigned to the node in the jth regression tree associated with covariate value Xi and treatment level w, and the
number of regression trees J is considered to be fixed and known. The details of the specification of prior distribution and
the choice of hyper-parameters can be found in Chipman et al.37. Sampling from the posterior distributions proceed via a
Bayesian backfitting MCMC algorithm37. A total of L Markov Chain Monte Carlo (MCMC) samples of model parameters,
(Tj ,Mj), are drawn from their posterior distribution. For each of L draws, we predict the potential outcomes for each
unit and the relevant treatment level. The causal estimand of interest can be estimated by contrasting the imputed potential
outcomes between treatment groups. For example, ATT1|1,2 can be estimated as follows:
ÂTT 1|1,2 = (n1L)−1
L∑
l=1
∑
i:Wi=1
{
f l(1,Xi)− f l(2,Xi)
}
= (n1L)
−1
L∑
l=1
∑
i:Wi=1
{
Φ
[ J∑
j=1
gj(1,Xi;T
l
j ,M
l
j)
]
− Φ
[ J∑
j=1
gj(2,Xi;T
l
j ,M
l
j)
]}
,
(7)
where (T lj ,M
l
j) are the lth draw from the posterior distribution of (Tj ,Mj). We can obtain obtain the point and interval
estimates of the treatment effect directly using the summary of posterior samples.
Common Support
Because problems can arise when drawing inference to regions of the covariate space where there are insufficient number of
units in all treatment groups, propensity score based methods are typically equipped with strategies for defining a common
support region. For BART, there is no such a mechanism to prevent it from extrapolating over areas where a common support
does not exist.
For a binary treatment, one strategy is to discard units that fall beyond the range of the propensity score51,52. Hill and
Su39 argue that these strategies typically ignore the information embedded in the response variable, and propose alternative
discarding rules. Illustrative examples with one or two predictors were used to compare the two types of discarding strategies
and their implications on estimation of the causal effects and the proportion of inferential units retained. Advantages of
BART over the propensity score approach manifest in examples where there is lack of common support for variables only
predictive of treatment but not of the outcome or the treatment mechanism is more difficult to model. However, in practice,
identifying common support is often required for a high-dimensional covariate space. In addition, the two types of strategies
have not been compared in the multiple treatment setting.
To address these limitations, we propose a strategy for BART to define both a common support region and the
corresponding discarding rules. Whereas Hill and Su39 uses a common support for binary treatment using the 1 sd rule,
our empirical simulations suggest this rule may be too relaxed in the setting of three or more treatment groups. We use a
sharper cutoff and identify a common support as follows. We discard any unit i, with Wi = w, for which s
fw′
i > maxj{sfwj }
, ∀j : Wj = w, where sfwj and sfw′j denote the standard deviation of the posterior distribution of the potential outcomes under
treatment W = w and W = w′, respectively, for a given unit j.
For multiple treatments with Z = 3, when estimating the ATT of treatment W = 2 and W = 3 among those treated with
W = 1, we discard for unit i with Wi = 1, if
sf2i > maxj{sf1j }, and
sf3i > maxj{sf1j }.
(8)
When estimating the ATE, we apply the discarding rule in (8) to each treatment group.
There is likewise a lack of consensus for defining a common support region with GPS-based approaches. For matching
using the GPS,14 propose a rectangular support region. Let r(w,X) denote the treatment assignment probability for w, and
let r(w,X|W = w′) represent treatment assignment probability forw among those who received treatmentw′. A rectangular
common support region can be defined as follows with Z = 3. For any w,w′ ∈ W = {1, 2, 3},
r(w,X)low = max{min(r(w,X|W = 1)),min(r(w,X|W = 2)),min(r(w,X|W = 3))}
r(w,X)high = min{max(r(w,X|W = 1)),max(r(w,X|W = 2)),max(r(w,X|W = 3))} (9)
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For weighting methods, techniques such as trimming32 or stabilizing (more useful for time-varying confounding, see Hu
et al.53, Hu and Hogan54 and Herna´n and Robins55) are frequently used in place of a common support. However, the lack of
common support in the covariate space may lead to extreme weights and unstable IPTW estimators.
Simulation Studies
Design and implementation
We conduct expansive simulations in order to better understand how BART will work in complex causal settings. Our first
set of simulations, Simulation 1, contrasts BART with other approaches, while our second set, Simulation 2, looks into the
role that covariate overlap plays in inferences with multiple treatments.
The design of both simulations mimics the range of scenarios that are representative of the data structure in the SEER-
Medicare registry. Three treatment levels (Z = 3) are used throughout, with pairwise ATTs of risk difference are our outcome
of interest. True treatment effects are computed based on a simulated super-population of size 100,000. We replicated each of
the scenarios described below 200 times within sub-populations of the superpopulation. In Simulation 1, we began with the
comparisons of 10 methods: 1) RA; 2) IPTW with weights estimated using multinomial logistic regression (IPTW-MLR); 3)
IPTW with weights estimated using generalized boosted models (IPTW-GBM); 4) IPTW with weights estimated using super
learner (IPTW-SL); 5) IPTW-MLR with trimmed weights; 6) IPTW-GBM with trimmed weights; 7) IPTW-SL with trimmed
weights; 8) VM; 9) TMLE; 10) BART. We used VM to only estimate the ATT effects as the algorithm for estimating the
ATE has not been fully developed, and implemented TMLE to only estimate the ATE effects as we are not aware of any
implementation of TMLE for the estimation of ATT effects for multiple treatment options. In simulation 2, only BART,
TMLE and IPTW-GBM, the top performing methods in Simulation 1, were further examined.
We implemented the methods as follows. For RA, we first fit a Bayesian logistic regression model with main effects of
all confounders using the bayesglm() function in the arm package in R. We then drew a total of 1,000 MCMC samples
of regression coefficients from their posterior distributions and predicted the potential outcomes for each unit and relevant
treatment group. When implementing IPTW, we estimated GPSs by including each confounder additively to a multinomial
logistic regression model, a generalized boosted model, and a super learner model respectively. The stopping rule for the
optimal iteration of GBM was based on maximum of absolute standardized bias, which compares the distributions of the
covariates between treatment groups24. We implemented SL using the weightit() function in the R package WeightIt
for multinomial treatment and included three algorithms: main terms regression, generalized additive model, and support
vector. The treatment probabilities are normalized to sum to one. The weights – inverse of the GPSs – were then trimmed at
5% and 95% to generate trimmed IPTW estimators. GPSs for VM were estimated using multinomial logistic regression with
main effects of all confounders. We used a combination of k-means clustering with k = 5 subclasses and one-to-one matching
with replacement and a caliper of 0.25 to ensure that the matched cohort is relatively similar in terms of the distributions of
the confounders. We used the R package tmle to implement TMLE as described in Rose and Normand34. We used SL to
estimate each treatment probability and bound them from below to 0.025. Applying BART to the simulation datasets, we
used the default priors associated with the bart() function available in the BART package in R. For each BART fit, we
allowed the maximum number of trees in the sum to be 100. To ensure the convergence of the MCMC in BART, we let the
algorithm run for 5000 iterations with the first 3000 considered as burn-in.
To judge the appropriateness of each technique, we use mean absolute bias (MAB), root mean squared error (RMSE) and
coverage probability (CP). In addition, we examine the large-sample convergence property of each method.
Simulation 1: which causal approach yields the lowest bias and RMSE? We compare each of the 10 approaches across a
combination of two design factors: the study sample size (i.e., the total number of units) and the ratio of units in the treatment
groups. We varied the two factors in three scenarios: 1) 1200 with a 1:1:1 ratio, 2) 4000 with a 1:5:4 ratio, and 3) 11,600
with a 1:15:13 ratio to represent equal, moderately unequal and highly unequal sample sizes across treatment groups. The
relatively small sample size (400) in the first group – which will be used as the reference group of the ATT effects – and the
scenario of highly unequal sample sizes mimic the SEER-Medicare data in the motivating study.
We considered 10 confounders with five continuous variables and five categorical variables. We assumed that both
the treatment assignment mechanism and the response surfaces are nonlinear models of the confounders, as a realistic
representation of the application data. Specifically, the treatment assignment follows a multinomial logistic regression model,
ln
P (W = 1)
P (W = 3)
= α1 +Xξ
L
1 +Qξ
NL
1
ln
P (W = 2)
P (W = 3)
= α2 +Xξ
L
2 +Qξ
NL
2
(10)
where Q denotes the nonlinear transformations and higher-order terms of the predictors X, ξL1 and ξ
L
2 are vectors of
coefficients for the untransformed versions of the predictors X and ξNL1 and ξ
NL
2 for the transformed versions of the
predictors captured in Q. The intercepts, α1, α2, were specified to create the corresponding ratio of units in three treatment
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groups in each scenario. We generated three sets of parallel response surfaces as follows:
E[Y (1)|X] = logit−1{τ1 +XγL +QγNL}
E[Y (2)|X] = logit−1{τ2 +XγL +QγNL}
E[Y (3)|X] = logit−1{τ3 +XγL +QγNL}
(11)
where regression coefficients (τ1, τ2, τ3, γL, and γNL) were chosen so that the prevalence rates in the treatment groups
were similar as the rates of respiratory complications observed in the SEER-Medicare data (see Table 3). By generating
nonparallel response surfaces across treatment groups, we can induce heterogeneous treatment effects. This topic warrants
a stand-alone research and is beyond the scope of this article. Details of model specification in Equation (10) and (11)
are given in Table S1 of Supplementary Materials. The observed outcome Y is related to the potential outcome Y (w) via
Yi =
∑
w∈{w1,w2,...,wZ} Yi(w)I(Wi = w).
Simulation 2: How do levels of covariate overlap impact causal estimates Only BART, TMLE and IPTW-GBM, the top
performing methods in Simulation 1, are used in Simulation 2, which more deeply examines the impact of covariate overlap.
We generated datasets following the simulation configuration of scenario 3 in Simulation 1, including the total sample
size, the ratio of units, the number of continuous and categorical confounders and the response surface models, to mimic
the SEER-Medicare dataset. To create varying covariate overlap that are “measurable” in degrees, we generate the treatment
variable and covariate distribution as follows.
Three levels of covariate overlap were designed: 1) weak – there is lack of overlap in the covariate space defined by all
10 confounders, 2) strong – there is strong overlap with respect to each of the 10 confounders, and 3) moderate – the five
categorical variables had sufficient overlap as in the strong scenario and overlap is lacking for the five continuous variables.
Two configurations were examined in the moderate scenario. All of the five continuous variables or only two of them were
included in the response surface models, resulting in one configuration where overlap was lacking for a variable that was a
true confounder and another configuration when overlap was lacking for a variable that was not predictive of the response
surface (therefore not a true confounder). This simulation is designed to make it difficult for any method to successfully
estimate the true treatment effect, as both the treatment assignment and the outcome are difficult to model. We simulated
datasets for each scenario as follows.
• Weak. We assumed that the treatment variable W followed a multinomial distribution, W ∼
Multinomial(N, p1, p2, p3), and generated the treatment assignment by setting N = 11600, p1 = .03, p2 = .52
and p3 = .45. The covariates were generated from the distributions conditional on treatment assignment to
create sufficient or lack of overlap. The continuous variables were generated independently from Xj |W =
1 ∼ N(−1, 1), Xj |W = 2 ∼ N(1, 1), Xj |W = 3 ∼ N(3, 1) for j = 1, . . . , 5. The categorical variables were
generated independently from Xj |W = 1 ∼ Multinomial(N, .3, .3, .4), Xj |W = 2 ∼ Multinomial(N, .6, .2, .2),
Xj |W = 3 ∼ Multinomial(N, .8, .1, .1), for j = 6, . . . , 10. The potential outcomes of each treatment group were
drawn from the response surface models (11), with all of the 10 covariates included (i.e., all covariates are true
confounders). Under this scenario, lack of overlap was designed for each of the 10 confounders.
• Strong. The treatment variable W was generated in the same way as in the weak scenario. We created strong
covariate overlap by generating similar distributions of the covariates across the treatment groups for all 10
confounders X1 −X10. Specifically, we assumed Xj |W ∼ N(.05W, 1− 0.05W ) for j = 1, . . . , 5, and Xj |W ∼
Multinomial(N, .3− .001W, .3 + .001W, .4) for j = 6, . . . , 10.
• Moderate. We generated five categorical confounders X6 −X10 with strong overlap, and lack of overlap for five
continuous variables X1 −X5. We distinguished the situation where overlap is lacking for a variable that is not
predictive of the outcome (moderate I) and the situation when it is lacking for a true confounder (moderate II).
Specifically, we assumed that Xj |W = 1 ∼ N(−0.5, 1), Xj |W = 2 ∼ N(1, 1), Xj |W = 3 ∼ N(2.5, 1) for j =
1, . . . , 5 and Xj |W ∼ Multinomial(N, .3− .001W, .3 + .001W, .4) for j = 6, . . . , 10. In moderate I, the response
surface models only included covariates X1, X5, X6 −X10, thus, X2, X3 and X4 that defined a covariate area in
which the lack of overlap ocurred are non-confounders. In moderate II, covariates X1 −X10 were all included in the
response surface model, inducing lack of overlap in five true confounders.
Distributions of estimated GPSs across the treatments are compared using boxplots. For each overlap scenario, we
estimated the GPS for each unit in the sample using GBM, and plotted the distributions of estimated GPSs using a separate
boxplot for the unit receiving each type of treatment (Figure 1). Substantial overlap in boxplots is presented in the strong
overlap scenario, while the weak overlap scenario highlights the different distributions of GPSs.
Simulation Results
Simulation 1 Table 1 displays the MAB, RMSE and CP of the estimates of two ATT effects ATT1|1,2 and ATT1|1,3, and
three ATE effects ATE1,2,ATE1,3 and ATE2,3, for the three scenarios in Simulation 1.
No single method trumped others in estimating both ATT1|1,2 and ATT1|1,3 across all three scenarios. For ATT1|1,2,
outcome modeling approaches had smaller MABs and RMSEs, whereas for ATT1|1,3, GPS approaches showed similar or
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(a) Weak Covariate Overlap
(b) Moderate Covariate Overlap
(c) Strong Covariate Overlap
Figure 1. Overlap assessment for the scenarios of weak, moderate and strong covariate overlap. Each panel presents boxplots by
treatment group of the estimated generalized propensity scores for one of the treatments, P (Wi = w|X), w ∈ {1, 2, 3}, for every
unit in the sample. The left panel presents treatment 1 (W = 1), the middle panel presents treatment 2 (W = 2), and the right
panel presents treatment 3 (W = 3).
slightly better performance than BART. RA performed best under the scenario of equal sample sizes. As the sample sizes
in the comparison groups grew relative to the reference group, BART generally produced low MAB and RMSE. With GPS
approaches, IPTW-GBM outperformed IPTW-MLR, IPTW-MLR-Trim, IPTW-SL and IPTW-SL-Trim in the estimates of
ATT1|1,2 across all three scenarios, but had similar performances in estimating ATT1|1,3. Weight trimming did not improve
IPTW-MLR, IPTW-GBM or IPTW-SL. VM presented larger bias and RMSE than BART and IPTW-GBM. None of the
methods had nominal CP. IPTW methods and RA in general generated greater than the nominal CP, VM had a CP that
decreased as the ratio of units became more unbalanced (0.99 to 0.80), and BART yielded a CP around 0.80 – 0.88, which
we suspect is because the reference group is relatively small. Overall, BART and IPTW-GBM tended to show the best
performances across settings for the ATT estimates.
For the ATE estimates, BART consistently provided lower MAB and RMSE followed by TMLE, across all three scenarios
with different ratio of units. BART had nominal CP across all three scenarios. IPTW methods and TMLE yielded conservative
intervals and greater than the nominal CP. RA was sensitive to the ratio of units. In the scenario with highly unequal
sample sizes across treatment groups, RA had subpar performance. The intervals produced by RA rarely covered the true
effects, resulting in a low CP. Altogether, BART and TMLE provided the best performances across settings for the ATE
estimates. Boxplots of biases from 200 replications in pairwise ATT and ATE estimates appear in Figure S1 and Figure S2
in Supplemental Materials.
In Figure 2, we examined the large-sample convergence property of each of six methods. We considered only the scenario
with the ratio of units = 1:15:13, which is the most representative of the SEER-Medicare registry. We simulated the data
with increasing sample sizes of n =(2900, 5800, 8700, 11,600, 14,500, 17,400).We computed the RMSE of the estimates of
ATT1|1,2 and ATT1|1,3 for each n. We then regressed log(RMSE) on (− log n) using a simple linear regression with a slope
b for each method. The least-squares estimation of b approximates the convergence rate56. BART and GBM converged at a
rate ofO(n−1/2) for both ATT estimates. IPTW-MLR, IPTW-SL, VM and RA all converged at a slower rate thanO(n−1/2).
Figure S3 in Supplemental Materials displays the convergence property of each of six method for the estimates of the ATE
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Table 1. Comparison of the estimated average treatment effects on the treated in terms of mean absolute bias (MAB), root mean
square error (RMSE) and coverage probability (CP) across 200 replications in Simulation 1. The causal estimand is based on risk
difference.
ATT1|1,2 ATT1|1,3 ATE1,2 ATE1,3 ATE2,3
Scenario Method MAB RMSE CP MAB RMSE CP MAB RMSE CP MAB RMSE CP MAB RMSE CP
RA 0.01 0.02 0.99 0.03 0.04 0.99 0.01 0.02 0.99 0.03 0.04 0.98 0.02 0.02 0.99
IPTW-MLR 0.06 0.07 1 0.04 0.05 1 0.07 0.08 1 0.04 0.05 1 0.09 0.10 1
IPTW-MLR-Trim 0.06 0.07 1 0.04 0.05 1 0.07 0.08 1 0.04 0.05 1 0.09 0.10 1
IPTW-GBM 0.05 0.06 0.99 0.05 0.06 0.98 0.07 0.07 1 0.06 0.07 0.98 0.13 0.13 0.96
I IPTW-GBM-Trim 0.06 0.07 0.99 0.05 0.06 0.98 0.06 0.06 0.98 0.06 0.07 1 0.11 0.12 0.96
IPTW-SL 0.06 0.07 1 0.05 0.06 1 0.07 0.08 1 0.05 0.06 1 0.12 0.13 1
IPTW-SL-Trim 0.06 0.07 1 0.06 0.08 1 0.06 0.07 1 0.05 0.05 1 0.10 0.11 1
VM 0.05 0.07 0.99 0.06 0.08 0.93 – – – – – – – – –
BART 0.03 0.04 0.88 0.04 0.05 0.80 0.03 0.03 0.96 0.03 0.03 0.95 0.03 0.04 0.95
TMLE – – – – – – 0.04 0.05 1 0.02 0.03 1 0.05 0.06 1
RA 0.02 0.02 1 0.05 0.05 0.92 0.02 0.02 0.80 0.05 0.05 0.60 0.03 0.03 0.67
IPTW-MLR 0.05 0.06 1 0.03 0.03 0.99 0.06 0.08 1 0.04 0.05 1 0.07 0.07 1
IPTW-MLR-Trim 0.06 0.06 1 0.03 0.03 0.99 0.06 0.07 1 0.03 0.04 1 0.08 0.08 1
IPTW-GBM 0.03 0.04 0.98 0.03 0.04 0.99 0.05 0.05 0.98 0.05 0.06 1 0.09 0.09 0.94
II IPTW-GBM-Trim 0.05 0.06 0.98 0.04 0.04 0.99 0.05 0.05 0.98 0.05 0.06 1 0.09 0.09 1
IPTW-SL 0.06 0.06 1 0.04 0.04 0.99 0.06 0.07 1 0.05 0.05 1 0.11 0.11 1
IPTW-SL-Trim 0.06 0.07 1 0.06 0.06 0.99 0.06 0.07 1 0.05 0.05 1 0.10 0.10 1
VM 0.04 0.05 0.86 0.05 0.07 0.88 – – – – – – – – –
BART 0.02 0.03 0.80 0.03 0.04 0.75 0.02 0.02 0.96 0.01 0.02 0.98 0.01 0.02 0.94
TMLE – – – – – – 0.04 0.04 1 0.02 0.02 1 0.04 0.04 0.96
RA 0.03 0.03 1 0.07 0.07 0.44 0.03 0.03 0.06 0.07 0.07 0.03 0.04 0.04 0.03
IPTW-MLR 0.06 0.06 1 0.02 0.03 0.73 0.07 0.08 1 0.05 0.06 1 0.07 0.07 1
IPTW-MLR-Trim 0.06 0.07 1 0.02 0.03 1 0.06 0.07 1 0.03 0.04 1 0.07 0.08 1
IPTW-GBM 0.03 0.04 1 0.02 0.03 0.98 0.04 0.05 0.98 0.04 0.05 1 0.06 0.06 0.98
III IPTW-GBM-Trim 0.06 0.06 1 0.02 0.03 0.98 0.04 0.05 1 0.05 0.05 1 0.06 0.06 0.10
IPTW-SL 0.06 0.06 0.99 0.03 0.03 1 0.06 0.07 1 0.04 0.05 1 0.10 0.10 1
IPTW-SL-Trim 0.06 0.07 0.99 0.04 0.05 1 0.06 0.07 1 0.04 0.05 1 0.10 0.10 0.99
VM 0.03 0.04 0.80 0.05 0.06 0.78 – – – – – – – – –
BART 0.02 0.03 0.76 0.03 0.04 0.74 0.02 0.03 0.95 0.02 0.03 0.96 0.01 0.01 0.94
TMLE – – – – – – 0.03 0.03 0.98 0.01 0.02 0.97 0.03 0.03 0.96
estimates. BART and TMLE converged at a rate of O(n−1/2) for all of the pairwise ATE estimates. GBM varied in the rate
of convergence across three pairwise ATE effects, from O(n−1/2) to O(n−2/5) to O(n−1/3). IPTW-MLR, IPTW-S and RA
all had a much slower convergence rate.
Simulation 2 Figure 3 displays boxplots of biases of ATT1|1,2 and ATT1|1,3 among 200 simulations under four levels of
overlap for each of IPTW-GBM, IPTW-GBM with trimmed weights, BART and BART with discarding rules (Figure 3(a));
and boxplots of biases of ATE1,2, ATE1,3 and ATE2,3 for each of TMLE, BART and BART with discarding rules
(Figure 3(b)).
BART boasts smaller bias under nearly all levels of overlap compared to TMLE and IPTW-GBM. The advantage is more
evident when there is more lack of covariate overlap. The larger biases and RMSEs (see Table S2 in Supplemental Materials)
in the IPTW-GBM estimates under the weak scenario relative to moderate and strong overlap suggest that weighting by the
GPS – even by employing flexible machine learning techniques – suffers from insufficient covariate overlap. The doubly
robust method, TMLE, did not show as much variation in its performance across different levels of covariate overlap. In
addition, in the weak scenario, weight trimming largely altered the IPTW-GBM estimates, indicating the lack of overlap
may have led to extreme GPSs. GPS methods ignore the information in the outcome variable, thus assessing covariate
overlap regardless of whether the variables are true confounders; BART, on the contrary, takes advantage of the information
contributed by the outcome. This is demonstrated by the similar performance delivered by IPTW-GBM in moderateI (lack
of overlap in non-confounders) and moderateII (lack of overlap in true confounders), and better performance of BART in
moderateI than in moderateII. BART perhaps recognized, in moderateI, that X2, X3 and X4 do not play an important role
in the response surface, and showed a better performance than IPTW-GBM (smaller bias in both treatment effects).
Our BART discarding rule (8) considerably reduced the biases in the estimates of both ATE and ATT effects in the
weak scenario where there was substantial lack of covariate overlap. When the lack of covariate overlap was moderate, the
discarding strategy noticeably improved over plain BART. When there was sufficient covariate overlap, BART with and
without discarding performed equally well. The weighting methods and TMLE are not coupled with discarding rules. To get
a sense of the proportion of units that would be retained in the common support region for inference based on the GPSs,
we applied the GPS-based discarding rule, employed by VM, designed for obtaining a common support region for multiple
treatments (9). Using BART, the percentages of discarded units in the treated group, averaged across 200 replications, in the
weak, moderateI, moderateII and strong scenario were 38%, 24%, 15% and 0.2%, respectively, as compared to 86%, 42%,
42% and 13% computed by the GPS-based discarding rule (9). BART retains a much larger common support region while
providing more accurate treatment effect estimates.
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Figure 2. The large-sample convergence rate of each of six methods for the estimates of two treatment effects, ATT1|1,2 and
ATT1|1,3. BART and IPTW-GBM converged the fastest, approximately at a rate of O(n−1/2). RA converged the slowest,
approximately at a rate of O(n−1/20).
Application to SEER-Medicare Data on NSCLC
Clinical encounter and Medicare claims data on 11,980 patients with stage I-IIIA NSCLC was drawn from the latest SEER-
Medicare database. These patients were above 65 years of age, diagnosed between 2008 (first year patients in the registry
underwent robotic-assisted surgery) and 2013, and underwent surgical resection via one of the three approaches, including
robotic-assisted surgery, VATS or open thoractomy. The dataset contains individual-level information at baseline on the
following variables: age, gender, marital status, race, ethnicity, income level, comorbidities, cancer stage, tumor size, tumor
site, cancer histology and whether they underwent positron emission tomography (PET), chest computer tomography (CT)
or mediastinoscopy. Table 2 summarizes these variables for each surgical approach. We compared the effectiveness of the
three surgical approaches in terms of four outcomes: the presence of respiratory complication within 30 days of surgery or
during the hospitalization in which the primary surgical procedure was performed, prolonged length of stay (LOS) (i.e., >
14 days), intensive care unit (ICU) stay following surgery and readmission within 30 days of surgery. Table 3 displays the
outcome rates in the three surgical groups.
Among the 11,980 patients, 396 (3.3%) received robotic-assisted surgery, 6582 (54.9%) underwent VATS, and 5002
(41.8%) were operated via open thoracotomy. We estimated the causal effects of robotic-assisted surgery vs. VATS
or open thoracotomy among patients underwent robotic-assisted surgery (i.e., ATTs1|s1,s2 and ATTs1|s1,s3 ) and in the
overall population (i.e., ATEs1,s2 and ATEs1,s3 ) using BART, regression adjustment, IPTW with GPSs estimated using
multinomial logistic regression or GBM (with or without trimming), and VM. Each method was implemented as described
in the simulation section. All pre-treatment covariates were included additively to the GPS models for IPTW methods and
VM, and to the response surface models for RA and BART.
Table S3 in Supplemental Materials presents the point and interval estimates ofATTs1|s1,s2 andATTs1|s1,s3 based on risk
difference for all the methods examined. To provide uncertainty intervals for the treatment effect estimates, nonparametric
bootstrap was used for the IPTW methods and VM, and Bayesian posterior intervals were used for RA and BART. All
methods yielded statistically insignificant effects on respiratory complication and readmission if patients who received
robotic-assisted surgery had instead been treated with open thoracotomy or VATS. For prolonged LOS and ICU stay, all
methods except RA and VM suggested that robotic-assisted surgery led to significant smaller rates of the outcomes compared
to open thoracotomy, but no statistically significant differences compared to VATS. The results from this empirical dataset
provided partial evidence that robotic-assisted surgery may have a positive effect on some postoperative outcomes among
those who were operated with robotic-assisted surgery compared to open resection, but no advantages on over VATS.
To highlight the importance of simultaneous comparisons of multiple treatments, we implemented each method using
SBC to show how such inappropriate practices can result in different and confusing estimates of treatment effects. Table S3
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(a) BART-discard vs. GBM for ATT estimates
(b) BART-discard vs. TMLE for ATE estimates
Figure 3. Biases among 200 replications under scenarios of differing covariate overlap for IPTW-GBM vs. BART and two treatment
effects ATT1|1,2 and ATT1|1,3; and for TMLE vs. BART and three treatment effects ATE1,2, ATE1,3 and ATE2,3.
also includes the estimates of ATTs1|s1,s2 and ATTs1|s1,s3 from SBC. For BART, the conclusions are generally consistent
with those using multiple treatment comparisons, though we note several inconsistent directions of the estimates of treatment
effects. Given the different estimands and subpopulations to which inference using SBC is generalizable when using GPS-
based approaches, it would generally be inappropriate to directly compare causal estimates. However, we note that IPTW
methods, implemented using SBC, did not always match the findings that were based on IPTW methods designed for multiple
treatments. Details appear in Table S4 in Supplementary Materials.
We further explored the sensitivity of BART for binary outcomes to the choice of end-node prior, specifically via the
hyperparameter k 40. We employed 5-fold cross-validation to choose the optimal k that minimizes the misclassification error.
Results suggested the optimal hyperparameter k = 2, which is the default value of k in the bart() function (not shown).
Moreover, we extended the 1 sd rule, the discarding rule of BART proposed by Hill and Su39, to the multiple treatment
setting, to assess whether common support between treatment groups is reasonable based on the uncertainty in the posterior
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Table 2. Baseline characteristics of patients in three surgical groups in SEER-Medicare data.
Robotic-Assisted Surgery VATS Open Thoracotomy
Characteristics N = 396 N = 6582 N = 5002
Age (years), mean (SD) 74.3 (5.7) 73.9 (5.4) 74.5 (5.7)
Female, N (%) 223 (56.3) 3446 (52.4) 2941 (58.8)
Married, N (%) 227 (57.3) 3753 (57.0) 2802 (56.0)
Race, N (%)
White 320 (80.8) 5694 (86.5) 4369 (87.3)
Black 21 (5.3) 364 (5.5) 248 (5.0)
Hispanic 15 (3.8) 218 (3.3) 139 (2.8)
Other 40 (10.1) 306 (4.6) 246 (4.9)
Median household annual income, N (%)
1st quartile 97 (24.5) 2132 (32.4) 1009 (20.2)
2nd quartile 88 (22.2) 1729 (26.3) 1193 (23.9)
3rd quartile 98 (24.7) 1345 (20.4) 1143 (22.9)
4th quartile 113 (28.5) 1376 (20.9) 1657 (33.1)
Charlson comorbidity score, N (%)
0− 1 154 (38.9) 2163 (32.9) 1810 (36.2)
1− 2 113 (28.5) 1944 (29.5) 1379 (27.6)
> 2 129 (32.6) 2475 (37.6) 1813 (36.2)
Year of diagnosis, N (%)
2008-2009 14(3.5) 2686 (40.8) 1484 (29.7)
2010 33 (8.3) 1123 (17.1) 857 (17.1)
2011 85 (21.5) 1033 (15.7) 866 (17.3)
2012 131 (33.1) 899 (13.7) 821 (16.4)
2013 133 (33.6) 841 (12.8) 974 (19.5)
Cancer stage, N (%)
Stage I 295 (74.5) 4195 (63.7) 3884 (77.6)
Stage II 63 (15.9) 1504 (22.9) 709 (14.2)
Stage IIIA 38 (9.6) 883 (13.4) 409 (8.2)
Tumor size, in mm, N (%)
≤ 20 160 (40.4) 1967 (29.9) 2232 (44.6)
21− 30 98 (24.7) 1696 (25.8) 1388 (27.7)
31− 50 109 (27.5) 1804 (27.4) 987 (19.7)
≥ 51 29 (7.3) 1084 (16.5) 367 (7.3)
Histology, N (%)
Adenocarcinoma 255 (64.4) 3757 (57.1) 3348 (66.9)
Squamous cell carcinoma 107 (27.0) 2165 (32.9) 1167 (23.3)
Other histology 34 (8.6) 660 (10.0) 487 (9.7)
Tumor site, N (%)
Upper lobe 215 (54.3) 3829 (58.2) 2859 (57.2)
Middle lobe 27 (6.8) 308 (4.7) 335 (6.7)
Lower lobe 141 (35.6) 2195 (33.3) 1720 (34.4)
Other site 13 (3.3) 250 (3.8) 88 (1.8)
PET scan, N (%) 302 (76.3) 5004 (76.0) 3410 (68.2)
Chest CT, N (%) 263 (66.4) 4525 (68.7) 3148 (62.9)
Mediastinoscopy, N (%) 62 (15.7) 715 (10.9) 420 (8.4)
Abbreviations: PET = positron emission tomography; SD = standard deviation; CT = computer tomography
Table 3. The outcome rates in three surgical groups: robotic-assisted surgery, VATS and open thoracotomy.
Outcomes Robotic-Assisted Surgery VATS Open Thoracotomy Overall
N = 396 N = 6582 N = 5002 N = 11960
Respiratory complication 30.1% 33.6% 33.3% 33.3%
Prolonged LOS 5.3% 10.4% 5.5% 8.2%
ICU Stay 60.2% 75.3% 59.1% 67.9%
Readmission 8.8% 9.8% 8.0% 9.0%
predictive distributions associated with the outcome in the observed versus the counter-factual treatment group. We did not
exclude any patients from the empirical dataset based on the discarding rule in (8).
Summary and Discussion
Our paper makes two primary contributions to the causal inference literature. First, we extend BART to the multiple
treatment and binary outcome setting, highlighting that the strengths of BART for binary treatment also manifest with
multiple treatments. Second, we propose a common support rule for BART, and find that BART consistently shows superior
performance over alternative approaches in various scenarios with differing levels of covariate overlap.
In addition to the primary findings in our simulations corresponding to bias, RMSE, CP and large-sample convergence
property. BART boasts a few additional advantages that make it a unique tool for the multiple treatment setting. As one
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example, BART is computationally efficient. All simulations were run in R on a iMAC with a 4GHz Intel Core i7 processor.
On a dataset of size n=11,600, each BART implementation took less than 150 seconds to run, while each IPTW-GBM
implentation took about 10 minutes to run. As a second example, BART produces coherent interval estimates of the treatment
effects for either continuous or binary outcomes using posterior samples. For GBM, McCaffrey et al.24 estimate the variance
by using robust procedure for continuous outcomes, but acknowledge that there is currently lack of theory to guarantee that
this approach results in proper confidence intervals. For estimands based on a binary outcome such as the risk difference
investigated in this article, it is difficult to approximate the variance using robust procedure. For matching based approaches,
there is still ambiguity regarding appropriate methods for interval estimation14,20,38.
We apply the methods examined to 11,980 stage I-IIIA NSCLC patients, drawn from the latest SEER-Medicare linkage.
Results suggest that robotic-assisted surgery may be preferred in terms of prolonged LOS and ICU stay, among those who
were operated via the robotic-assisted technology, relative to open thoracotomy or VATS. Different choice of methods,
or inappropriate practice such as implementing SBC for pairwise ATT effects, may lead to different conclusions about
the treatment effects, explicating the importance of appropriate methods and practice for causal inference with multiple
treatments.
The promising performance of BART in the complex multiple treatment settings will lay groundwork for several future
research avenues. First, the flexibility offered by nonparametric modeling of BART can be leveraged to model regression
relationships in survival data. Second, individual treatment effects that are easily obtained from BART provide a building
block for estimating the heterogeneous treatment effect. Finally, we have made a significant untestable assumption related to
unmeasured confounding. Developing sensitivity analyses under this complex multiple treatments setting leveraging BART
would also be a worthwhile and important contribution.
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